Skip to main navigation
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • Tango
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • Rett Syndrome
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
    • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
Stoke Therapeutics
  • Contact Us
  • LinkedIn
  • Twitter
  • About Stoke
    • Overview
    • Leadership
    • Founders
    • Corporate Responsibility
  • Scientific Platform
    • Overview
    • Tango
    • Publications
  • Disease Areas
    • Overview
    • Dravet Syndrome
    • ADOA
    • Rett Syndrome
    • SYNGAP1
    • Pipeline
  • Patients & Families
    • Overview
    • Clinical Studies
    • Expanded Access Policy
    • Educational Resources
  • Careers & Culture
    • Overview
    • Job Opportunities
    • Diversity, Inclusion & Belonging
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
  • Home
  • Investors & News
  • Financials & SEC Filings
  • SEC Filing Details

SEC Filing Details

Document Details

Form
DRS
Filing Date
March 26, 2019
Document Date
March 26, 2019
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Stoke Therapeutics
Issuer
Stoke Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
Email Alerts
Contact IR
Investor FAQs
  • About Stoke
  • Scientific Platform
  • Disease Areas
  • Patients & Families
  • Careers & Culture
  • Investors & News
  • Contact Us
Stoke Logo

© 2023 Stoke Therapeutics, all rights reserved.

  • Privacy Policy
  • Terms of Use
  • Site Map
  • LinkedIn
  • Twitter